| A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants (NCT07341672) | Sunshine Lake Pharma Co., Ltd. | 2026-12-31 |
| Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function (NCT05048368) | Sunshine Lake Pharma Co., Ltd. | 2026-10-30 |
| Single-ascending Dose Study of HEC-151 Injection (NCT07376200) | Sunshine Lake Pharma Co., Ltd. | 2026-02-24 |
| A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B (NCT07771140) | Sunshine Lake Pharma Co., Ltd. | 2025-12-02 |
| Clinical Study on the Mass Balance of Clifutinib (NCT07211165) | Sunshine Lake Pharma Co., Ltd. | 2025-09-29 |
| A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects (NCT07102251) | Sunshine Lake Pharma Co., Ltd. | 2025-09-21 |
| A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects (NCT07099118) | Sunshine Lake Pharma Co., Ltd. | 2025-09-03 |
| ADME Study of [14C] Yiqibuvir in Healthy Male Subjects (NCT05998304) | Sunshine Lake Pharma Co., Ltd. | 2023-08-07 |
| A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China (NCT05802862) | Sunshine Lake Pharma Co., Ltd. | 2023-07-06 |
| HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML (NCT05586074) | Sunshine Lake Pharma Co., Ltd. | 2023-03-03 |
| A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients (NCT05139719) | Sunshine Lake Pharma Co., Ltd. | 2023-02-15 |
| Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations (NCT04992858) | Sunshine Lake Pharma Co., Ltd. | 2022-11-27 |
| ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects (NCT05446233) | Sunshine Lake Pharma Co., Ltd. | 2022-11-15 |
| Clifutinib Food Effect Study in Healthy Subjects (NCT05454098) | Sunshine Lake Pharma Co., Ltd. | 2022-11-08 |
| Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114 (NCT05504876) | Sunshine Lake Pharma Co., Ltd. | 2022-11-07 |
| A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML (NCT05133882) | Sunshine Lake Pharma Co., Ltd. | 2022-10-31 |
| HEC169096 in Participants With Advanced Solid Tumors (NCT05451602) | Sunshine Lake Pharma Co., Ltd. | 2022-10-21 |
| Study on the Body Mass Balance and Biotransformation of [14C]-HEC585 (NCT05468346) | Sunshine Lake Pharma Co., Ltd. | 2022-07-26 |
| A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects (NCT05459285) | Sunshine Lake Pharma Co., Ltd. | 2022-05-31 |
| A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment (NCT05374343) | Sunshine Lake Pharma Co., Ltd. | 2022-05-05 |
| A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage (NCT05427682) | Sunshine Lake Pharma Co., Ltd. | 2022-04-19 |
| Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects (NCT05497674) | Sunshine Lake Pharma Co., Ltd. | 2022-02-21 |
| The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder (NCT04984512) | Sunshine Lake Pharma Co., Ltd. | 2021-12-14 |
| ADME Study of [14C]- Rongliflozin in Healthy Male Subjects (NCT05109078) | Sunshine Lake Pharma Co., Ltd. | 2021-12-09 |
| A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants (NCT05057949) | Sunshine Lake Pharma Co., Ltd. | 2021-11-24 |
| ADME Study of [14C]- Larotinib in Healthy Male Subjects (NCT05059743) | Sunshine Lake Pharma Co., Ltd. | 2021-11-20 |
| Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study (NCT05391360) | Sunshine Lake Pharma Co., Ltd. | 2021-10-11 |
| A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects (NCT05576298) | Sunshine Lake Pharma Co., Ltd. | 2021-10-08 |
| Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. (NCT04925674) | Sunshine Lake Pharma Co., Ltd. | 2021-09-10 |
| Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects (NCT04982913) | Sunshine Lake Pharma Co., Ltd. | 2021-08-24 |
| Phase ll Study of HEC585 in Patients With IPF (NCT05060822) | Sunshine Lake Pharma Co., Ltd. | 2021-06-30 |
| Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects (NCT07588646) | Sunshine Lake Pharma Co., Ltd. | 2021-06-29 |
| To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers (NCT05383131) | Sunshine Lake Pharma Co., Ltd. | 2021-06-23 |
| Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C (NCT05395416) | Sunshine Lake Pharma Co., Ltd. | 2021-06-21 |
| Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects (NCT05492630) | Sunshine Lake Pharma Co., Ltd. | 2021-05-24 |
| Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD (NCT04565171) | Sunshine Lake Pharma Co., Ltd. | 2021-04-15 |
| A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies (NCT04865458) | Sunshine Lake Pharma Co., Ltd. | 2021-04-01 |
| Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer (NCT04415853) | Sunshine Lake Pharma Co., Ltd. | 2021-01-21 |
| Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects (NCT04625361) | Sunshine Lake Pharma Co., Ltd. | 2021-01-20 |
| the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets (NCT04667429) | Sunshine Lake Pharma Co., Ltd. | 2021-01-18 |
| GLS4/RTV and TAF Drug-drug Interaction (NCT04551261) | Sunshine Lake Pharma Co., Ltd. | 2021-01-10 |
| To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects (NCT04552808) | Sunshine Lake Pharma Co., Ltd. | 2020-10-19 |
| Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study (NCT04536532) | Sunshine Lake Pharma Co., Ltd. | 2020-10-09 |
| Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects (NCT04546984) | Sunshine Lake Pharma Co., Ltd. | 2020-09-14 |
| The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects (NCT04422496) | Sunshine Lake Pharma Co., Ltd. | 2020-08-10 |
| Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects (NCT04232514) | Sunshine Lake Pharma Co., Ltd. | 2020-07-15 |
| Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects (NCT04512170) | Sunshine Lake Pharma Co., Ltd. | 2020-07-13 |
| The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects (NCT04202952) | Sunshine Lake Pharma Co., Ltd. | 2020-07-06 |
| A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects (NCT05294536) | Sunshine Lake Pharma Co., Ltd. | 2020-06-22 |
| The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects (NCT04596007) | Sunshine Lake Pharma Co., Ltd. | 2020-04-01 |
| the Safety, Tolerability, and Pharmacokinetics Study of HEC113995 (NCT04623814) | Sunshine Lake Pharma Co., Ltd. | 2020-03-30 |
| The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects (NCT04194242) | Sunshine Lake Pharma Co., Ltd. | 2020-01-03 |
| The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects (NCT04201275) | Sunshine Lake Pharma Co., Ltd. | 2019-12-18 |
| Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer (NCT04131192) | Sunshine Lake Pharma Co., Ltd. | 2019-11-11 |
| The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects (NCT04591301) | Sunshine Lake Pharma Co., Ltd. | 2019-07-04 |
| The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects (NCT03943251) | Sunshine Lake Pharma Co., Ltd. | 2019-07-04 |
| HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers (NCT03886688) | Sunshine Lake Pharma Co., Ltd. | 2019-05-14 |
| The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects (NCT03903081) | Sunshine Lake Pharma Co., Ltd. | 2019-03-06 |
| Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection (NCT04147208) | Sunshine Lake Pharma Co., Ltd. | 2019-02-28 |
| Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors (NCT04324372) | Sunshine Lake Pharma Co., Ltd. | 2019-02-27 |
| The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects (NCT03655873) | Sunshine Lake Pharma Co., Ltd. | 2018-11-21 |
| The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects (NCT03663686) | Sunshine Lake Pharma Co., Ltd. | 2018-10-25 |
| The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects (NCT03673696) | Sunshine Lake Pharma Co., Ltd. | 2018-09-04 |
| A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects (NCT03662568) | Sunshine Lake Pharma Co., Ltd. | 2018-06-26 |
| A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC (NCT03876925) | Sunshine Lake Pharma Co., Ltd. | 2018-06-25 |
| A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML) (NCT04827069) | Sunshine Lake Pharma Co., Ltd. | 2018-05-18 |
| The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (NCT03502902) | Sunshine Lake Pharma Co., Ltd. | 2018-04-26 |
| Phase 3 Study of Yimitasvir Phosphate Capsules (NCT03487107) | Sunshine Lake Pharma Co., Ltd. | 2018-04-17 |
| The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects (NCT03811678) | Sunshine Lake Pharma Co., Ltd. | 2018-01-11 |
| A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML) (NCT03125876) | Sunshine Lake Pharma Co., Ltd. | 2017-11-13 |